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ABSTRACT
STRUCTURE-SUBSTRATE BINDING RELATIONSHIPS
OF HIV-1 REVERSE TRANSCRIPTASE
Steve Chien-Wen Huang
Old Dominion University
and
Eastern Virginia Medical School
1994
Director: Dr. Laura K. Moen

Human Immunodeficiency Virus, type 1 (HIV-1), is the causative agent of the
Acquired Immunodeficiency Syndrome (AIDS). HIV-1 reverse transcriptase (RT),
a heterodimer p66/p51, has been the major target for treatment of AIDS. The
significance of the p51 subunit and the RNase H domain of p66 in terms of their
influence on the RNA-dependent DNA synthesis was investigated. Clones of the
wildtype HIV-1 RT subunits, p66 and p51, and a recombinant C-terminal deletion
mutant, p64, [Barr, P. J. (1987) Bio/Technoloav 5, 486-489] were employed to
study the structure-substrate binding relationships of HIV-1 RT. The activity
assays of RNA-dependent DNA synthesis on both poly(rA)(dT) and a random
base RNA template hybridized with a DNA oligomer showed that p51 significantly
affects the enzyme activity. The increase in processivity by p51 in the p66/p51
heterodimer was also demonstrated. These observations suggested that the
integrity of p51 is important in subunit-interactions for maintaining a favorable
conformation of the enzyme for optimal function. C-terminal deletion in p66 was
seen to decrease the processivity. The dissociation constant (Kd) for poly(rA)(dT)
obtained by nitrocellulose binding assays suggested that the processivity of HIV-
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1 RT on poly(rA)(dT) correlated with the affinity for the substrate. The
processivity of RT on RNA335-DNA20 was seen to be affected by the pause
sites observed on the autoradiograms. The pauses of DNA synthesis tended to
occur at positions of template containing poly G-C sequences. The order of
processivity observed on RNA335-DNA20 was p64/p64, p66/p66 < p64/p51 <
p66/p51. The C-terminal deletion in p66 was shown to affect the ability to extend
the DNA strand on RNA template.

In those non-wildtype forms of HIV-1 RT

(p66/p66, p64/p64, and p64/p51), the affinity for primer-template seemed to be
sensitive to the structure of the RNA template as seen when comparing Kds
between poly(rA)(dT) and RNA335-DNA20. The wildtype enzyme, p66/p51,
appeared to have a similar affinity for both substrates.
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I. Introduction

Human Immunodeficiency Virus, type 1 (HIV-1), is thought to be the
causative agent of the Acquired Immunodeficiency Syndrome (AIDS) (1-5). HIV1 reverse transcriptase (RT), an important viral enzyme responsible for
converting the viral RNA genome into viral DNA after infection, has been the
major target for treatment of AIDS (6-19). Although many inhibitors are known,
such

as

3'-azido-3'deoxythym idine

(AZT),

ddC

and

ddl

which

are

dideoxymononucleoside analogs that cause chain termination during DNA
polymerization, the use of these drugs is compounded by serious side effects
such as bone marrow suppression, resumption of virus replication during therapy,
and emergence of AZT-resistant HIV-1 mutants (20-22).

Deeper knowledge

regarding the molecular structure of this enzyme along with its enzymatic
mechanism is highly desirable to develop a better drug design.

History of HIV (1-5)
AIDS, an infectious disease spread by blood, by sexual intercourse, and
from mother to child, has become an epidemic since the first AIDS cases were
diagnosed in 1981 among young homosexual men in the U.S.

HIV was

discovered to be the causative agent during the two years from mid-1982 to mid1984 (5). It was first observed that all AIDS victims suffered from a depletion of
T4 cells, a specific subset of T cells. And it was suspected that a species of
retrovirus, like HTLV-I which can infect T lymphocytes and cause highly
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malignant cancer, was the pathogen. The evidence started with the finding that
the reverse transcriptase activity, a main characteristic of retroviruses, was
detected in the swollen lymph node of a young homosexual (5). This pathogen
was identified as a new retrovirus. This new virus was found to grow only in T4
cells and not in the related cells called T8. Electron micrographs of the new virus
were different from those of HTLV-I. Also, a viral protein p25 (or p24) found in
the AIDS pathogen was not present in HTLV-I.

A blood test was eventually

formulated to show that this new virus was present in almost all people with
AIDS, in a variable proportion of people who had received blood contaminated by
the virus, and in no healthy heterosexuals (5). It was then firmly established that
the new virus is the cause of AIDS and the virus was named as Human
Immunodeficiency Virus, HIV.

Life cycle of HIV
HIV was later found to infect not only T4 cells but also macrophages (23).
HIV enters its target cells by interacting with the molecule called CD4 (23). CD4
has a significant role in the immune function of T4 lymphocytes and is also found
in the smaller numbers on some macrophages, allowing them to be infected. The
life cycle of HIV is shown in Figure 1. The genes of a retrovirus are encoded as
RNA. The cycle begins when an HIV particle binds to the outside of a cell and
injects its core (23). The core includes two identical strands of RNA as well as
structural proteins and enzymes. One enzyme, called reverse transcriptase, is
responsible for converting the viral genetic information into DNA. The enzyme
first makes a single-stranded DNA copy of the viral RNA, destroys the original
RNA, and then makes a second DNA copy using the first one as the template
(23). The viral genetic information, now in the form of double-stranded DNA,
migrates to the cell nucleus. A second viral enzyme, called integrase, splices the
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Figure 1 Life cycle of HIV. HIV infection begins when a virion, or virus particle,
binds to the outside of a susceptible cell by the interaction between viral GP120
and host CD4 proteins. The virion then fuses with the cell, injecting the core
proteins and two strands of RNA. The double-stranded DNA, synthesized by viral
reverse transcriptase on the RNA genome, migrates to the nucleus and is
integrated into the cell's own DNA. The provirus can then remain latent, giving no
sign of its presence. Alternatively, it can commandeer the cellular mechanism to
transcribe its genes into RNA, some of which are translated into proteins on
ribosome. The proteins and the RNA genome are then assembled into new
virions that bud from the cell (23).
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HIV genome into the host cell DNA. The viral DNA will be duplicated with the
cell's own genes every time the cell divides (23). The expression of the viral
genes is regulated by the nucleotide sequence in the so-called long terminal
repeats (LTR's) (23). LTR's are stretches of DNA at the ends of the viral genome
which can direct enzymes belonging to the host cell to copy the proviral DNA into
RNA. Some of the RNA will provide the genetic material for a new generation of
virus.

Certain other RNA strands serve as the mRNA's that guide cellular

machinery in producing the structural proteins and enzymes of the new virus.
Two different protein molecules in a ratio of about 20 to one will be assembled
with the RNA genome (23). The more abundant molecule (gag ) is the precursor
of the protein shell that will enclose the RNA and enzyme in the complete virions.
The other m olecule (gag-pol) is larger; it contains the same structural
components but includes additional segments that will become the viral enzymes.
The two proteins migrate to the periphery of the cell as they are produced, a fatty
acid at the end of each one attaches it to the inside of the cell membrane. As
these precursors aggregate, they bind to one another and form a spherical
structure that bulges outward under the cell membrane. Two strands of the viral
RNA are drawn into this nascent virion as it takes shape. One of the enzymes
contained in the gag-pol precursor, the viral protease, cuts itself free of the
protein chain and cleaves the reverse transcriptase, the integrase and the
additional molecules of protease. It then cleaves the gag polypeptides and what
is left of the gag-pol

polypeptides into four segments each.

Three of the

segments collapse to form a bullet-shape core surrounding the RNA and
enzymes but the remaining segments stay attached to the inside of the cell
membrane. The viral envelope proteins, which jut from the membrane like a set
of spikes are made and transported to the cell surface independently of the core
proteins.

Each spike is a complex of two or three identical units that in turn
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consist of two components: gp120 and gp41. These glycoprotein complexes are
crucial to HIV's ability to infect new cells. The virions will sweep up the cell
membrane with envelope proteins to enclose the core and release from the host.

Current therapeutic methods of RT inhibition
HIV-1 RT is responsible for converting the viral RNA into DNA and hence is
the major target for antiviral treatment. Most of the effective inhibitors of HIV-1
RT are nucleoside analogs, the 2',3'-dideoxynucleosides, including AZT (20-22).
These dideoxynucleosides are missing the 3-hydroxyl which is required for
further deoxynucleoside monophosphate (dNMP) incorporation. It is observed
that HIV-1 RT has a higher affinity for dideoxynucleotides than for normal
substrates (22). They inhibit HIV-1 RT after they are metabolized in vivo to the
appropriate triphosphates by terminating the DNA chain growth. Unfortunately,
all of these compounds have toxicities that limit their usefulness in the treatment
for AIDS.

For example, the most frequent toxicity of AZT is bone marrow

suppression.
observed.

In addition, the emergence of the drug resistant strains is
Com parative nucleotide sequence analysis of the reverse

transcriptase-coding region from AZT sensitive and resistant isolates reveals four
common amino acid substitutions: Asp67Asn, Lys70Arg, Thr215Phe, and
Lys219Gln (22).
A variety of benzodiazepine and dipyridodiazepine derivatives have been
identified as potent antiviral agents inhibiting HIV-1 RT as non-nucleoside analog
inhibitors (50, 68, 69). Most appear to bind to a site on HIV-1 RT near T y r l81
which is distinct from the substrate binding site. Unlike the dideoxynucleoside
analogs that can inhibit a number of human and animal retroviral DNA
polymerases, these two groups of compounds are highly specific to HIV-1 RT.
Several drugs selected from these two groups are under preclinical or clinical
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development. One of these non-nucleoside analogs, Nevirapine, is found to bind
in a deep pocket that lies between beta sheet of the palm and the base of the
thumb (50). It has been suggested that the binding of Nevirapine could prevent
the movement of the thumb subdomain relative to the thumb subdomain during
DNA synthesis or affect the conformation of the active site.
Despite intensive research efforts to identify compounds which inhibit HIV-1
RT, only AZT and ddl have been licensed to date for the treatment for HIV-1
infection.

There is still great need to develop new drugs that have less

cytotoxicity and are active against viral isolates resistant to AZT or ddl. Deeper
knowledge about the structure and function relationships of HIV-1 RT is highly
desirable for the development of more specific inhibitors.

Structure of HIV-1 RT
As shown in Figure 2, HIV-1 RT is encoded by gag-pol mRNA where the 5'
end of the po/open reading frame overlaps the 31end of gag with the po/frame
by one nucleotide in the 51direction (-1) (24). Ribosome frame-shifting is utilized
to produce the gag-pol polypeptide which, in turn, gives rise to HIV-1 RT. In
both virions and infected cells, HIV-1 RT has been characterized as a
heterodimer consisting of two subunits: p66 and p51 (25-30). The two subunits
have identical amino termini because p51 is derived by proteolytic processing of
p66 by the viral protease with the cleavage site at Phe440-Tyr441 (31-35). It has
been determined that the DNA polymerase and RNase H activities of HIV-1 RT
map to the amino- and carboxyl- terminal portions connection region called the
tether domain (28, 41, 46, 47). The p51 subunit lacks the RNase H domain. It
has been reported that enzymatic activity is almost exclusively confined to the
dimeric form of the enzyme and only one primer-template binding site is present
in a dimer (48, 49). It has also been shown that the p66 subunit provides the
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Figure 2 Schematic representation of the pol gene of H I\M RT and its
relationship to protease, RT and integrase.

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

7

env

pol

gag

Protease

Integrase

Reverse Transcriptase

N-terminal

C-terminal

Pol

tether

RNaseH

P66
P51 E

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

8

polymerization active site in the p66/p51 heterodimer (49). According to the
crystal structure, the p66 subunit is folded into five separate regions: the RNase
H domain, the connection domain, and three subdomains of the pol domain,
namely fingers , palm, and thumb (50, Figure 3). The p66 subunit is highly
elongated in folding, having dimensions of approximately 110 by 30 by 45 A0, and
a cleft is formed by the finger, palm, and thumb subdomains (50).

The

conformation of p51 is astonishingly different from that of p66, although both bear
the same amino acid sequences (50). Unlike p66, p51 has no cleft, and residues
thought to be involved in catalysis (Asp185, Asp186, Asp110) are essentially
buried (50). The thumb domain is further from the fingers and palm subdomains.
The connection domain lies within and fills the expanded cleft (50). The tip of the
fingers and the connection domain of p51 interact with the palm and connection
sudomains of p66 (50). The extended thumb of p51 contacts the RNase H
domain of p66 (50). The crystal structure of HIV-1 RT implies that one of the p66
subunits of the p66/p66 homodimer should assume the conformation of p51 and
unravel its RNase H domain for cleavage (50).

Function of HIV-1 RT
HIV-1 RT can polymerize a DNA strand from either an RNA or a DNA
template. The enzyme also encodes an RNase H activity that hydrolyzes the
RNA of RNA-DNA duplexes (51-57). As shown in Figure 4, the primer for minus
strand DNA synthesis is a specific tRNA(*-ys) molecule that is packaged in the
virion and base paired to the primer-binding site (PBS) located near the 5' end of
the RNA genome (58). Synthesis of the minus strand is initiated from the 3‘ end
of the tRNA molecule and continued to the end of the viral genome.

The

hybridized RNA ( R and U5 sequences) is removed and the short DNA minus
strand is translocated to the 3' end of the same or a second RNA molecule,

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 3 A stereo a-carbon model of p66/p51. The p66 subunit is in blue
color. The fingers, thumb, palm, connection, and RNase H subdomains are
indicated by arrows. Residues 539 - 560 of p66 (the region deleted in p64) are
shown in green. The p51 subunit is in white color. The double helix in red is the
template-primer. Model was generated with SYBYL on a Silicon Graphics
computer from the a-carbon coordinates reported by [Arnold, E. et al. (1992)
Nature 357. 85-89],
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Figure 4 The process of reverse transcription by HIV-1 RT (58).
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By reconstituting p66, p51, and p64, we have been able to use four forms
of enzymes for structure-function study. One form, p66/p51, is the wildtype
heterodimer.

Another, p66/p66, is the homodimer which contains an extra

RNase H domain (p15) in the non-catalytic subunit.

The mutant heterodimer,

p64/p51, has 22 amino acid residues deleted in the C-terminus and lacks the
RNase H function, and p64/p64 is the mutant homodimer that contains Cterminal deletion at p66 and has an extra stretch of polypeptide in the noncatalytic subunit.
The activity assays of RNA-dependent DNA synthesis on both poly(rA)(dT)
and RNA335-DNA20 demonstrated that the replacement of p51 for the noncatalytic subunit significantly increases the enzyme activity (Figure 12, 13, 20,
and 21). The results showed that the conditions used for reconstitution in this
study favor the formation of a more active enzyme, the heterodimer. This result
was supported by the observation that the enzyme activity is exclusively confined
to the dimer forms in an investigation of the process of dimer formation and the
properties of the different mono- and dimeric forms of HIV-1 RT (28, 93). Also, it
has been shown that individually purified p66 and p51 were capable of binding to
form 1 : 1 heterodimer with an association constant 10-fold greater than that
observed for p66/p66 homodimer formation (101).
The reconstituted heterodimer, in both wildtype and mutant, was shown to
have better processivity on poly(rA)(dT) (Figures 14 -17). Since monomeric p66
has little activity (28, 93), these increases in enzyme activity and processivity
suggested that the p51 polypeptide has an important role in the enzyme structure
and function.

One possible role could be that p51 improves the enzyme

processivity through its contribution to a better primer-template interaction and/or
a better conformation of the enzyme active site. The primer-template interaction
with the enzyme was hence investigated.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 5 DNA polymerase mechanism of HIV-1 RT. A bireactant biproduct
mechanism has been proposed for DNA synthesis by HIV-1 RT. In this
mechanism, binding of the reactants is ordered with the primer-template binding
first followed by the binding of the dNTP that is complementary to the next
appropriate template residue. The incorporation of dNMP into the nascent chain
then occurs via an Sn2 displacement of pyrophosphate (the first product) of the
dNTP by the 3' hydroxyl at the primer terminus. Multiple dNMP additions can
occur before the enzyme dissociates from the extended primer-template, the
second product.
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pyrophosphate (the first product) of the dNTP by the 3' hydroxyl at the primer
terminus.

Multiple dNMP additions can occur before the enzyme dissociates

from the extended primer-template, the second product. HIV-1 RT is highly errorprone and produces approximately 5 to 10 nucleotide errors per genome every
round of replication in vivo (67). This high error rate of HIV-1 RT is believed to be
responsible for the hypermutability of HIV (67).
The RNase H domain of HIV-1 RT was assigned to the residues Glu348
through Ile559 of the polypeptide (47). Asp443, Glu478, Asp498, and Asp549
were suggested to be important in RNase H activity (98). The HIV-1 RT RNase
H domain was found to display both endonuclease and 3' to 5' exonuclease
activities (86). The distance between the RNase H and polymerase active sites
was found to correspond to the length of a 15-16 nucleotide DNA-RNA
heteroduplex (99). Also, it was found that the RNase H function is much less
active than the polymerase function during processive DNA synthesis (87). The
endonuclease function of RNase H domain was found to be in the direction of 3'
to 5' and displayed a partially processive activity.

The RNase H domain

expressed in bacteria was found to be inactive by itself, and the addition of the
p51 polypeptide led to enzymatic activity (84). This observation suggested the
interdependence of polymerase and RNase H domains.

Interaction between HIV-1 RT and primer-template
In the crystal structure of HIV-1 RT, an obvious groove which exists
between the RNase H domain and polymerase domain is presumably the primertemplate binding site (50). DNA synthesis on an RNA template by HIV-1 RT is
accompanied by the cleavage of the RNA template by RNase H; the RNase H
cleavage site has been estimated to be some 15 to 16 nucleotides downstream
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of the synthesis. Thus, the RNA-DNA duplex of the primer-template must lie
between these two active sites with the 3' end of the RNA contacting the RNase
H active site marked by the binding of the divalent cations in the crystal structure,
and the 3' end of the DNA of the duplex in contact with the DNA polymerase
active site. In a fitting m o d e l, the RNA-DNA can be fit snugly into the groove
observed in the crystal structure when the DNA is modestly bent toward the
protein. The cross-linking of dT15 to HIV-1 RT homodimers showed the cross
links at residues Leu289 to Thr290 and Leu295 to Thr296 which are in the thumb
subdomain (69). It is also reported that the N-terminus of residues 1 to 230 of
HIV-1 RT is capable of nucleic acid binding (70). The location of p51 relative to
the RNA-DNA-HIV-1 RT fitting model suggests that the connection domain of p51
has a possible role in binding the tRNA-template complex by contacting the
duplex as well as the eighteen anticodon and D stems and loops of tRNA (50).
Steady-state analyses have been performed on HIV-1 RT to determine the
dissociation constant for primer-template.

A sum mary of the measured

dissociation constants of the wild-type HIV-1 RT (p66/p51) for primer-template is
given in Table 1. Huber et al. (67) have demonstrated that HIV-1 RT forms a
stable complex with poly(rA)(dT) primer-template in the absence of Mg~ and
dTTP with a Kd of 3 nM. Krug et al. (63) have used globin mRNA hybridized to
dT15 and demonstrated that Kd calculated by Scatchard method is 11 nM. The
amount of globin mRNA-dT bound to the enzyme is obtained by extrapolating the
burst of incorporation at zero time. Reardon's studies (71) have revealed a Kd
of 10 nM for HIV-1 RT binding to a template-primer (RNA44-DNA21) by
measuring the burst of product formation upon addition of dTTP. Kati etal. (72)
have used rapid transient kinetic method with defined synthetic RNA45-DNA25 to
obtain a Kd of 10 nM for the interaction between HIV-1 RT and this templateprimer. Hsieh e tal. (73), using a quadratic binding equation: [E.D] = 0.5 ([E]t+
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Table 1 Summary of the measured dissociation constants of HIV-1 RT
(p66/p51) for primer-template.
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[D]t + Kd) - 0.5 ( [E],+ [D], + Kd) 2 - 4 [E], [D], )1/2>have obtained a Kd of 26 nM
for the interaction between HIV-1 RT and a DNA32-DNA23 template-primer.
Binding of this 23/32-mer primer-template by HIV-1 RT was also examined by the
gel mobility shift assay and results fit to a hyperbolic binding cun/e with Kd of 15
nM. Beard

et al. (74) have used a template-prim er challenge assay to

quantitatively follow RT-template-primer complex formation and observed that
HIV-1 RT ( both p66/p66 and p66/p51) bind to poly (rA)(dT)16 tightly with a Kd < 1
nM. As shown in Table 1 all the values are in nM range. Also, the Kd for poly
(rA)(dT)n was found to be dependent on the length of the primer; short primer
binding had a lower affinity.

Processivity and pausing of HIV-1 RT DNA synthesis
The processivity of a polymerase is defined as the number of nucleotides
polymerized during a single binding event or cycle and describes the competition
between elongation in the bound state and dissociation from template-primer
(75). When DNA polymerases conduct one cycle of synthesis (processive DNA
synthesis), the template position for termination of DNA synthesis (pausing) is
non-random on heteropolymeric templates (76). Pausing occurs preferentially at
certain nucleotide positions and termination probabilities vary at different
template positions (77).

HIV-1 RT has to polymerize approximately 20,000

nucleotides to complete the conversion of single-stranded RNA genome into
double-stranded

proviral DNA (78).

Following infection by HIV in culture,

synthesis of the proviral DNA is completed within 4 to 8 hours (79, 80). Thus,
HIV-1 RT polymerizes DNA at an average rate of about 1 nucleotide per second
in vivo. In vitro, the processivity of HIV-1 RT ranges from about 1 nucleotide on
poly dA to about 300 nucleotides on poly rA and on some M13 templates (67,
81). HIV-1 RT processivity is relatively low compared to the other replicative
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polymerases and is observed to be strongly influenced by the template
sequences (82). Studies of the structure of HIV-1 RT and its relationship with the
processivity and pausing during DNA synthesis are important for understanding
viral replication in vivQ. These studies should include the evaluation of the ability
of template sequence to influence termination of DNA synthesis by HIV-1 RT.

Contribution of RNase H domain of p66 to processivity of DNA synthesis by
HIV-1 RT
As described previously, the RNase H domain of HIV-1 RT resides in the
carboxyl-terminal part of the protein.

HIV-1 RT RNase H function has been

identified as involving endo- as well as exonuclease activity (63). The carboxyl
terminal region of HIV-1 RT has been recovered from an enzyme preparation
from virus particles as an indepedent p i 5 protein, and a combination of
recombinant p15 and p51 leads to reconstitution of RNase H activity (83, 84).
The coordination between RNase H activity and RNA-dependent DNA synthesis
has been investigated. Models in which there is a tight coupling between DNA
polymerization and RNA hydrolysis have been proposed (64, 85-86). However,
evidence that RNase H function is less active than the polymerase function
during processive DNA synthesis supports the uncoupled model (87, 88).
Defects in RNase H function were found to disturb DNA polymerase activity of
HIV-1 RT. AGIn475Glu mutant of HIV-1 RT, which has partially impaired RNase
H activity, failed to hydrolyze homopolymeric substrates and showed a reduced
processivity of the RNA dependent DNA polymerase (89). Two mutants of HIV-1
RT, Asp443Asn and Asp443Asn/Asp498Asn lost detectable RNase H activity but
appeared to retain wild-type activity of DNA synthesis on homopolymeric RNA
templates (90). However, on heteropolymeric RNA templates derived from the
gag region of HIV-1, these mutants could poorly extend the terminated nascent
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primer. It has been suggested that a catalytically functional RNase H domain is
required to facilitate the reinitiation of DNA synthesis at specific pause sites along
a heteropolymeric template (90). This suggestion is supported by the observation
that the inability of the RNase H negative mutant to hydrolyze the RNA template
blocked further DNA synthesis (91).

It has also been suggested that

conformation alteration induced by mutations in the RNase H domain can affect
the favorable primer-template binding required for processive DNA synthesis
(91).

Bavand et al. have studied the polymerization properties of the p51

homodimer. They concluded that the principal effect of the RNase H domain on
polymerase function is that it contributes to the stabilization of the p51 subunit
conformation in the heterodimer which is necessary for formation of the Michaelis
complex (92).

Contribution of P51 to HIV-1 RT activity
Sequence alignments of RTs and other polymerases have suggested that
the p66 subunit of the HIV-1 RT contains all the sequence information needed for
activity (48). Also, it has been shown that the p66 chain provides the polymerase
active site in the p66/p51 heterodimer (41,49). The monomeric forms of the HIV1 RT, p66 and p51, have been shown to be enzymatically inert (93). Dissociation
of either heterodimeric (p66/p51) or homodimeric (p66/p66 and p51/p51)
recombinant HIV-1 RT leads to loss of RNA-dependent DNA polymerase activity
in the resulting monomer, and it was reported that homologous HIV-1 RT
subunits can rapidly associate to form active heterodimer (94).

Hence

monomeric p66, although it contains all the sequence information needed for
activity, requires the interaction with a second polypeptide to maintain the
favorable conformation for enzyme activity.
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In the crystal structure of HIV-1 RT, the folding of the p51 polypeptide was
found to be astonishingly different from that of p66 (50). Unlike p66, p51 has no
cleft for the primer-template binding, and the residues involved in catalysis are
essentially buried. The two subunits interact in a manner such that the tip of the
fingers and the connection subdomains of p51 interact with the palm and
connection subdomains of p66 while the very extended thumb of p51 contacts
the RNase H domain of p66. It is conceivable that the p66 monomer by itself
would adopt a conformation similar to p51 and that this conformation might lack
the physical cleft for primer-template binding.

However, the protein-protein

interactions of p66 with p51 (or p66 in homodimer) enables p66 to induce an
enzymatically active conformation.

Effect of primer length on affinity for substrate
It has been shown that the Kd for poly(rA)(dT)n is dependent on the length of
the primer, with short primers binding with a lower affinity (74). Short oligo (dT)
primers (less than 14 nucleotides), annealed to poly(rA), bound RT relatively
weakly (Kd = 20 - 30 nM), whereas oligo (dT) primers of 16 and 20 nucleotides in
length bound tightly to RT (Kd - 0.1 nM) (74). The weak affinity is thought to be
due to the fact that the dissociation of the RT-template-primer complex is much
more rapid when the primer is short (74). Since, from the computer substrate
binding model, the RNA-DNA duplex needs to contact both DNA polymerase and
RNase H active sites and fit into a groove mainly folded by the p66 subunit, the
short primer might cause insufficient interaction with the substrate binding groove
and consequently make the primer-template easier to dissociate from RT than
the substrate with long primer.
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Significance of this investigation
The modeling of the binding of an RNA/DNA strand into the cleft shown in
the crystal structure (50) suggested that significant contacts between the RNase
H domain and the primer-template are occurring. As described before, point
mutations in the RNase H domain can impair the RNase H function and hinder
DNA synthesis as well (89-91).

It is important to investigate the correlation

between primer-template binding and DNA synthesis of the RNase H negative
enzyme.
In order to study the structure and function relationships of different forms of
HIV-1 RT, a well characterized recombinant C-terminal deletion mutant of HIV-1
RT will be employed. This mutant enzyme of HIV-1 RT has been cloned and
expressed in S . ce re v is ia e (35,95).

A brief description of the genetic

manipulation of this mutant clone as well as the p66 and p51 is given in Figure 6.
A DNA fragment from restriction digestion at sites Bal-1 (Trp179) and Kpn-1
(Trp690) of the HIV p o l open reading frame was fused with synthetic
oligonucleotide adapters for desired coding regions. The N-terminus is expanded
to Pro156 and the C-terminus to Ala693, Leu715, and Phe595 to construct three
clones: p64, p66, and p51 respectively. The RT gene is flanked by promoter and
terminator sequences of the yeast giyceraldehyde-3-phosphate dehydrogenase
(GAPDH) gene and inserted into pAB24, an autonomously replicating yeast
plasmid containing LEU2 and URA3 markers for selection.

The purified

polypeptide, p64, which is missing of 22 amino acid residues in the RNase H
domain of p66, lacks RNase H activity but retains the DNA polymerase activity
(35, 95, 96). Heard et al. have demonstrated that p64 has the standard ordered
Bi-Bi- mechanism as shown in wild-type enzyme with less affinity for the primertemplate (97).
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Figure 6 Schematic relationship of HIV-1 RT clones (35,95).
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In this investigation, the specific aims are as follow s:
1. Reconstitution of the different forms of HIV-1 RT.
P66, p51, and p64 (the C-terminal deletion mutant) will be used to generate
wildtype (p66/p51) heterodimer, p66/p66 homodimer, p64/p64 homodimer, and
p64/p51 heterodimer by a reconstitution method. The interactions of p66 or p64
with p51 as heterodimers (p66/p51 and p64/p51) will be examined. The increase
in DNA polymerase activity in both wildtype and mutant heterodimers of HIV-1
RT relative to the homodimers will be expected if the catalytic subunits are
interacting with p51 such that a favorable structure for DNA synthesis is adopted.
2. Investigation of the function of the C-terminal region in p66 on primer-template
binding.
The dissociation constant for primer-template will be studied among these
four forms of HIV-1 RT. p66/p66 is the form of HIV-1 RT whose small subunit
contains an extra stretch of RNase H domain (p15) instead of p51 only as in the
wildtype.

The extra p15 might cause p66, the catalytic subunit, to adopt a

conformation which affects primer-template binding. Also, the extra p15 might
have a physical contact with primer-template and hence influence the primertemplate binding. By comparing homodimers with p66/p51 heterodimers, the
effect of this extra p15 on primer-template binding will be examined. P64/p5l is
the form of HIV-1 RT which has 22 amino acid residues deleted at the C-terminus
of p66. The truncated RNase H domain might cause the loss of the affinity for
primer-template. This dissociation constant for primer-template of this mutant
heterodimer will be compared to that of wild-type enzyme. p64/p64 is the form of
HIV-1 RT which has not only an extra stretch of polypeptide on the small subunit,
but also a 22 amino acid residue deletion in the RNase H domain of p66. The
effect of these double defects on the primer-template binding will be examined.
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3. Investigation o f the function of C-terminal region in p66 on processivity.
The processivity of RNA-dependent DNA synthesis will be compared among
these different forms of HIV-1 RT. The extra stretch of polypeptide in p66/p66
might have altered the conformation of the catalytic subunit and hence influence
the processivity of the enzyme. In p64/p51, the structure of the small subunit is
as that in the wild-type, but the deletion in the catalytic subunit causes a defect in
RNase H function. p64/p51 is not able to hydrolyze the RNA on the RNA-DNA
duplex and hence might create blocks for DNA synthesis and hinder processivity.
In p64/p64, the catalytic subunit assumes an altered conformation due to the
interaction with p64 and lacks RNase H function. The processivity of this mutant
enzyme will be compared to those in wild-type enzyme and p64/p51. Besides
using poly(rA)(dT) as the primer-template for this investigation, a random base
RNA template is synthesized to serve as a template for DNA synthesis by HIV-1
RT. The significance of this template is that it is a natural substrate as that in
vivo and, since the sequence of this template is known, the relationship between
the primer extension pattern and the template sequence can be investigated.
4. Investigation o f the function o f the C-terminal deletion in p66 on primerextension pattern.
The relationship between the processivity of DNA synthesis by HIV-1 RT
and RNA template sequence will be investigated.

The synthesized RNA

template is 335 bases long and has a random sequence of ribonucleotides. By
hybridizing the RNA template with a DNA 20-mer, 78 nucleotides can be
incorporated to the 3' end of the primer.

The primer extension pattern by

p66/p66, p66/p51, p64/p64 and p64/p51 will be examined.

The template

sequence where DNA synthesis pauses will be compared.
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5. Investigation of the effect of primer length on the primer-template binding to
p64/p51 mutant heterodimer
As described before, Beard et al. have reported that the Kd for poly(rA)(dT)n
is dependent on the length of the primer with lower affinity for the short primer
(74).

The primer-template binding of p64/p51 will be characterized for its

dependence on the primer length.
RNA335 template.

A DNA 12-mer will be annealed to the

The Kd for RNA335-DNA12 and RNA335-DNA20 will be

compared to investigate if the C-terminal deletion mutant shows lower affinity for
the primer-template with shorter primer as in the wild type.
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II. Materials and Methods

Materials
Adenine. T y r o s i n e . L v s i n e . U r i d i n e .

Phenylalanine. Tryptophan.

Methionine. Arginine, and Histidine: Purchased from Sigama.
AMV-RT (8.000 U/ml): Purchased from Promega.
Bacto- agar: Purchased from DIFCO.
P-mercaptoethanol: Purchased from BioRad.
BSA: Purchased from Promega as nuclease free stock solution at 10 mg/ml.
Coomasie plus protein assay reagent: Purchased from Pierce.
CytoScint scintillation cocktail: Purchased from ICN.
2l-Deoxythymidine-5l>Triphosphate(dTTP).
2l-Deoxyadenosine-5'-Triphosphate (dATP).
2lDeoxvauanosine-5,-Triphosphate (dGTP).
and 2l-Deoxvcvtidine-5l-TriPhosphate fdCTPI
: Purchased from Sigma and prepared as a 100 mM stock solution .
Dithiothreitol (DTT): Purchased from Fisher are prepared as a 1.0 M stock
solution.
DNA 5'-End Labeling System: Purchased from Promega.
fgamma-32P] Adenosine-S'-Triphosphate: Purchased from ICN Biomedicals,
INC., 10 mCi/ml, 2.2 pM.
Gel filtration standards: Purchased from BioRad.
GF/C glass microfibre filters: Purchased from Fisher.
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Guanosine-5'-diphosphate: Purchased from Boehringer Mannheim.
Guanyl (3'-5‘) uridine: Purchased from Sigma.
KCI: Purchased from Fisher and prepared as a 4 M stock solution.
LB broth: Purchased from DIFCO.
[Methyl.I'^'.^Hl-Thymidine-S'-triphosphate (pHydTTP): Purchased from
Amersham,1.0 mCi, 8pM, 1.0 mCi/ml.
MgClfr Purchased from Fisher and prepared as 1 1.0 M stock solution.
NucTrap Push Columns: Purchased from Stratagene.
Oligomers ( 5 ’ GCT GGC GAA GGG GGG ATG TG 3'. 5' CTG GOA CGA CAG
GTT TCC CG 3‘ for PCR.

5‘ GGT CCA CGG TAT CGA TAA GC 3' for RT

assays): Purchased from The Midland Certified Reagent Company.
Peptone: Purchased from Sigma.
Pfu: Purchased from Stratagene.
Phenol (Molecular Biology Grade): Purchased from Fisher.
Phenylmethylsulfonyl fluoride (PMSF): Purchased from Sigma.
Polynucleotide phosphorylase: Purchased from United States Biochemical, 3.2
U/mg.
Polyriboadenosine-S'-monophosphate-Oligothmidine-S'monophosphate

P0ly(rA)(<jT)j2-1&:

Purchased from Pharmacia,S 2o.w for

p o iy (rA )=

5.8, poly(rA) to

jd T li 2- i 8 was 1:1.
Pvu II: Purchased from Promega.
Ribomax Large Scale RNA Production System -T7: Purchased from Promega.
RNA m olecular weight marker: Purchased from Boehringer Mannheim
Biochemica.
Sodium Pyrophosphate: Purchased from Fisher
S&S membrane filters: Purchased from Schleicher & Schuell, pore size : 0.45
pm, s iz e : 24 MM.
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Standard dialysis tubing (MWCO = 14.000): Purchased from Fisher.
Sterile filter: Purchased from Nalgene.
Superose 12 column: Purchased from Pharmacia.
100%Trichloroacetic acid (TCA): Purchased from Fisher in 500 g lots. Stock
solution was prepared by the addition of 227 ml of MilliQ water to the bottle.
Tris Base: Purchased from Fisher and prepared as a 1 M stock solution at
desired PH.
Triton X-100: Purchased from Fisher
Tryptone: Purchased from DIFCO.
TSK-Gel G3000SW column: Purchased from TosoHaas.
Ultrafiltration membrane: Purchased from Amicon.
Uridine-5'-diphosphate: Purchased from United States Biochemical.
Yeast extract: Purchased from DIFCO.
Yeast Nitrogen base w/o Amino Acids: Purchased from DIFCO.

Methods

Preparation of Leu M supplement
The Leu (-) supplement was prepared by combining 0.8 g of
Adenine, 0.6 g of Tyrosine, 0.6 g of Lysine, 0.6 g of uridine, 1 g of Phenylalanine,
0.4 g of Tryptophan, 0.4 g of Methionine, 0.4 g of Arginine, and 0.4 g of Histidine.

Preparation of Leu M rich media
The Leu (-) rich media was prepared by combining 10 ml of 10X yeast
nitrogen base w/o amino acids (prepared by dissolving 6.7 g of nitrogen base in
100 ml of MilliQ water), 0.5 g of Leu (-) amino acid supplement, 5 ml of 1%
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Tryptophan, 25 ml of 0.2% Adenine, 400 ml of 20% glucose, and 8 ml of 5%
Threonine. The total volume was brought up to 1 liter with MilliQ water. The
solution was sterilized by filtering through sterilizing membrane.

Preparation of YEP media
The YEP media was prepared by combining 20 g of peptone, 10 g of yeast
extract, and 920 ml of MilliQ water and autoclaving the solution. 25 ml of 0.2%
Adenine, 5 ml of 1% Tryptophan and 50 ml of 20% glucose were then added to
the solution.

Yeast cell culture
The yeast cell culture was prepared by inoculating 20 ml Leu(-) rich media
with 2 ml of yeast cells in a 250 ml bottle and shaking the culture at 30°C for 24
hours. The culture was transferred to a 1 liter bottle containing 100 ml of Leu (-)
rich media and shaken at 30°C for 24 hours. The culture was further transferred
to a 2 liter flask containing 1 liter of YEP media and shaken at 30°C for 30-36
hours. The yeast cells were then pelleted by centrifugation at 10,000 rpm in JA14 rotor at 4°C for 20 minutes. The cell pellets were stored at - 70°C.

Preparation of veast cell Ivsis buffer
The yeast cell lysis buffer was prepared by combining the following
quantities of stock solutions : 100 ml of 10X RT buffer (500 mM Tris, pH 7.8 , 2
mM EDTA, 1% Triton X-100, and 500 M KCI), 700 ml of MilliQ water, 200 ml of
glycerol, 3.7 g of KCI, 1.41 g of EDTA, and 154 pi of p-mercaptoethanol. The final
solution contains 50 mM Tris, pH 7.8, 0.1% Triton X-100, 100 mM KCI, 20%
glycerol, 4 mM EDTA, and 10 mM P-mercaptoethanol.
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Protein purification
The cloning of HIV-1 RT: pAB24/RT5 (p66), pAB24/RT6 (p51), and
pAB24/RT4 (p64), in yeast has been described previously (Figure 6). The pellets
from yeast cell culture were used for RT purification. Yeast cell pellets (from 1
liter yeast cell cultures) were broken by glass bead lysis in 200 ml of lysis buffer
in the presence of 1 mM PMSF. The lysis mixture was centrifuged at 10,000
rpm, 0°C for 30 minutes. The supernatant was transferred to a cold beaker and
(NH4)2S 0 4 (39.8 g per 100 ml of the supernatant) was added to salt out the
proteins. The mixture was pelleted by centrifugation at 10,000 rpm, 0°C for 30
minutes. The muddy pellets were then transferred into a dialysis tubing (MWCO =
14,000) and dialyzed in 4 liters of 1X RT buffer (50 mM Tris, pH 7.8, 0.2 mM
EDTA, 0.1% Triton X-100, 50 mM KCI, 10% glycerol, 10 mM (3-mercaptoethanol)
overnight.

The desalted mixture was then applied to a Whatman P11

phosphocellulose column equilibrated in 1X RT buffer and eluted with a linear 50800 mM KCI gradient. Fractions containing RT were determined by SDS-PAGE
(10%), protein assay, and activity assay, and these fractions were pooled.
Pooled fractions were concentrated and desalted in an Amicon pressure cell with
a YM30 membrane (Amicon, MWCO = 30,000 MW) under 50 psi at 4°C. The
concentrated fractions were then applied to an Affi-Blue column equilibrated in
1X RT buffer without KCI. The column was washed with one bed volume of RT
buffer (no KCI).

Proteins were eluted with a linear 50-600 mM KCI gradient.

Active fractions were pooled and concentrated as before. If necessary, RT was
further purified by gel filtration on a Superose 12 column (Pharmacia).

The

elution buffer contains 100 mM Tris, pH 8.5, 10 mM p-mercaptoethanol, 1 mM
EDTA, 0.1% Triton X-100, 50 mM KCI, and 10% glycerol. The purified protein
was concentrated to 1-2 pg/pl, divided into 50 pi aliquots and stored frozen at
-70°C. The purified enzyme was analyzed on SDS-PAGE as shown in Figure 7.
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Figure 7 SDS-PAGE analysis of p66, p64, p51, p66/p51, and p64/p 51.1 pg of
each RT homodimer and 2 pg of each RT heterodimer were analyzed on an SDS
polyacrylamide gel (10%) stained with Coomassie blue. Molecular weight
standards shown on the gel are 97.4, 66.2, 42.7, 31,21.5, and 14.4 KD.
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Also, the relationship between the amount of dTMPs incorporated

into

poly(rA)(dT) template-primer and enzyme concentration was shown in Figures 8
and 9 for p66/p66 and p64/p64 respectively to determine the optimal RT dilution
for further studies.

Protein assay
The protein assay used for determining the protein concentration during the
RT purification is based on the Bradford method which utilize an absorbance shift
in an acidic Coomassie Brilliant Blue G-250 solution. An absorbance shift from
465 to 595 nM occurs when Coomassie Blue G-250 binds to proteins in an acidic
solution. The color response is relatively linear to the protein concentration. 0-10
|ig/ml of BSA was used to obtain the linear relationship between the absorbance
at 595 nM and protein concentration.

The concentration of RT sample was

obtained by the absorbance and the linear equation of the standard curve.

Preparation of LB (Luria - Bertainil medium
The LB medium contains 10 g of Bacto-tryptone, 5 g of Bacto-yeast, and 10
g of NaCI in a water solution with final volume of 1 liter. The medium was
autoclaved. Ampicillin was added to 100 pig/ml after autoclaved solution was
cooled to 50°C.

Preparation of LB piate
15 g of agar was added to 1 liter of LB medium and autoclaved. Ampicillin
was added to 100 pg/ml when the solution was cooled to 55°C for LB-Amp plate.
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Figure 8 dTMP incorporation by purified p66. Poly(rA)(dT)12 -i 8 was used as
the template-primer and different dilutions of purified p66 were used in the
assays.
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Figure 9 dTMP incorporation by purified p64. Poly(rA)(dT)i2 - i 8 was used as
the template-primer and different dilutions of the purified p64 were used in the
assays.
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30-35 ml of medium was poured into each 100 mm petri dish. After the plates
hardened, they were stored at 4 °C .

Preparation of HB101 competent cells
1 ml of bacteria HB101 was inoculated into 10 ml of LB medium and
incubated overnight at 37°C in a shaking chamber. The culture was streaked on
an LB plate and incubated overnight at 37°C. One bacterial colony from the LB
plate was inoculated into 5 ml LB medium and incubated overnight at 37°C in a
shaking chamber. 1 ml of the bacterial culture was used to inoculate 100 ml of
LB incubated at 37°C in a shaking chamber for 2-4 hours until OD 550 = 0.5. 50
ml of the culture was put into each of two sterile centrifuge tubes, and they were
chilled on ice for 10 minutes. The cells were pelleted by centrifugation at 4,000 x
g (7,000 rpm) at 4°C for 5 minutes. They were resuspended in 25 ml of ice-cold,
sterile trituration buffer (50 mM CaC^and 10 mM Tris, pH 8.0). Placed in an ice
bath for 15 minutes, and centrifuged as before. The supernatant was decanted
and cells resuspended in 3.3 ml of trituration buffer. The final suspension of cells
was stored at-70°C.

Transformation of HB101 with plasmid Bluescript KS(+)
A 200 pi aliquot of HB101 competent cells was thawed on ice and 1-6 pi of
plasmid (40 ng/ml) was added. Cells were left on ice for 30 minutes and then
heat shocked at 42°C for 2 minutes. 1 ml of LB was added to each tube and the
mixtures were incubated at 37°C for 1 hour without shaking. 50 pi of the culture
was spread on LB-Amp plate and incubated at 37°C for 16-24 hours.
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Isolation of plasmid DNA from HB1 01/ p BS
A 2.5 ml overnight culture from a single colony was used to inoculate a 2liter flask containing 500 ml of LB-Amp medium.

The 500 ml culture was

incubated 12-16 hours at 37°C with shaking. The bacterial cells were harvested
by centrifugation at 4000 x g (10,000 rpm) at 4°C for 20 minutes. The pellet was
recovered and stored at -70°C if not used immediately. The pellet from the 500
ml culture was resuspended in 5 ml of solution I (50 mM glucose, 10 mM EDTA,
and 25 mM TrisCI, pH 8.0). After 10 minutes at room temperature, 10 ml of fresh
solution II (0.2 N NaOH and 1% SDS) was added. The suspension was stirred
and allowed to sit on ice for 10 minutes. 7.5 ml of solution III (3 M potassium
acetate and 11.5% glacial acetic acid) was added, mixed, and the solution was
chilled for another 10 minutes on ice. After centrifugation at 20,000 x g (13,000
rpm, JA20) at 4°C for 10 minutes, the supernatant was transferred to a fresh
tube, 0.6 volumes of isopropanol was added, and the sample was centrifuged
again at 15,000 x g (11,500 rpm, JA20). The pellet was washed with 2 volumes
of 70% ethanol and dried under vacuum. After resuspension in 4 ml of TE (10
mM TrisCI, pH 7.6, 1 mM EDTA), 4.4 g of CsCI and 0.4 ml of 10 mg/ml Ethidium
Bromide were added. The mixture was centrifuged at 350,000 x g (58,000 rpm,
VTi 65) for 20 hours. The lower band was collected by a needle and syringe, and
the Ethidium Bromide was removed by repeated extraction with isopropyl alcohol.
The CsCI was removed by dialysis in TE buffer.

Preparation of 10X RT assay buffer
The 10X RT assay buffer was prepared by combining the following
quantities of stock solutions: 1250 pi of 1 M Tris (pH 8.5), 145 pi of 1 M MgC^,
500 pi of 4.0 M KCI, 200 pi of 1M DTT, 125 pi of 10% Triton X-100, and 280 pi of
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MilliQ water.

The final volume was 2500 pi.

The buffer contains 500 mM Tris,

60 mM MgCl2, 800 mM KCI, 80 mM DTT, and 0.5% Triton X-100.

Preparation of polv(rAKd'n1?.1a stock solution
The lyophilized poly(rA)(dT)12-i8 (25 units) was dissolved by adding 15 pi of
4 M KCI and 781 pi of (10 mM Tris/ 1mM EDTA) to the bottle to make a final
concentration of 2.0 pg/ul. The molarity of the poly(rA)(dT)i2-is was obtained
from the following equation (119): Log(M) = 2.179 (Log (S20.W ) + 1.523).
molecular weight of 95968 g/mole was obtained from the
certificate of analysis.

S 2o,w

A

of 5.8 in the

The average base length corresponding to this

sedimentation constant is 258 polymerized adenosine-5-monophosphate bases.
Final stock concentration of the poiy(rA)(dT)12-i8 was 20.8 pM.

RT activity assay
The RT activity assays were carried out in a 50 pi mixture containing 50 mM
Tris (pH 8.5), 0.05% Triton X-100,10 mM MgCI2, 60 mM KCI, 8 mM DTT, 0.05%
Triton X-100, 6 mM MgCI2, 80 mM KCI, 2 pg of poiy(rA)(dT), 80 pM dTTP, and
0.25 mCi/nmol [3H]-dTTP. Reactions were initiated by the addition of 10 pi of
diluted enzyme to 40 pi of cocktail solution and incubated at 37°C for 30 minutes.
The reactions were quenched with 800 pi of ice cold 10% TCA containing 10 mM
PPi and maintained at 0°C until precipitated material was collected on Whatman
GF/C filters. Each filter was washed with 8 ml of the cold TCA solution and then
rinsed with 1-2 ml ethanol.

The dry filters were counted in a 5 ml CytoScint

scintillation cocktail in a Scintillation Counter. Activity of RT is indicated by the
amount of [3H]-dTTP incorporation in 30 minutes at 37°C.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

37

Nitrocellulose Binding Assays
The labeled primer-template was first prepared by using AMV-1 RT to
incorporate [3H]-dTTP onto poly(rA)(dT).

The labeled primer-template was

incubated with RT (0-10 nM) with RTB in a final volume of 800 pi for 15 minutes
at 0°C. The mixture was filtered through nitrocellulose filters to capture the
enzyme bound primer-template. The filters were placed in vials containing 5 ml
of scintillation cocktail and counted on a Beckman liquid scintillation counter. The
Kd was calculated by the Eadie plot method.

Polv(U.G) synthesis
Polynucleotide phosphorylase (0.5 units/ml) was incubated overnight at
37°C in a reaction mixture containing 0.15 M Tris, pH 9.0, 1 mM EDTA, 0.5mM
Guanyl (3'-5‘) uridine, 1mM MgCl2, 2 mM GDP, 2mM UDP, and 1 ml of water.
The poly(U,G) mixture was extracted with phenol and chloroform and
resuspended in 100 pi of TE buffer after ethanol precipitation. Concentration was
determined by optical density at 260 nM. Analysis of 5 pg of the sample by
agarose gel electrophoresis showed the average size to be 0.5 kb.

Processivity assays on polvfrAKdTI
Assays to determine the processivity of RTs were carried out by using
poly(U,G) as challengers. RT was incubated with poly(rA)(dT) (40 ng/pl) at 0°C
for 10 minutes and the reaction was initiated by adding MgCl2 (6mM), [3H]-dTTP
(80 pM, 0.25 mCi/nmol), and poly(U,G) (0.1-0.2 mg/ml).

The mixture was

incubated at 37°C and aliquots of 50 pi were removed at times over a 30 minutes
interval for counting to obtain the curve of time course incorporation. Assays
without poly(U,G) were also carried out for the control curve. The time required
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for one processive cycle was estimated from the point where the control and
poly(U.G) curves separate.

Enzvme Reconstitution
Reconstituted heterodimers, p66/p51 and p64/p51, were made by
incubating the corresponding enzyme preparations (p66 + p51 and p64 + p51) at
1:1 by weight in a buffer containing 100 mM Tris, pH 8.5, 10 mM pmercaptoethanol, 1 mM EDTA, 0.1% Triton X-100, 50 mM KCI, and 10% glycerol
at 4°C for more than 24 hours. The effect of reconstitution was determined by
comparing the activity of incorporating dTMPs onto primer-template.

Each

activity assay has a volume of 20 pi and contains dNTPs (50 pM), 1 pg of
poly(rA)(dT) or RNA335-DNA20 (0.5 pM), 0.5 pCi of [3H]-dTTP, and RT (0-25ng).

Polymerase Chain Reaction
Plasmid Bluescript (+) (the sequence is shown in Appendix 1) was used as
a template in a polymerase chain reaction to amplify a 446 bp fragment that
contains the T7 promoter sequence. Two primers have the sequences of 5'
GCTGG CGAAG GGGGG ATGTG3' and 5'CTGGC ACGAC AGGTT TCCCG 3'.
A 100 pi PCR reaction mixture is comprised of 24 pi of water, 10 pi of 10X PCR
buffer, 6 pi of 500 pM dNTPs, 2 pi of each 50 pM primer and 1 pi of 278 ng/pl
pBluescript. The 10X PCR buffer contains 60 mM Tris, pH 7.5, 500 mM NaCI, 60
mM MgCb, and 10 mM DTT. The mixture was initiated by heating at 95°C for
10 minutes followed by 30 amplification cycles of denaturing (95°C for 5
minutes), annealing (68°C for 5 minutes) and DNA synthesis (75°C for 5 minutes)
steps. The 446 bp DNA mixture was extracted with phenol and chloroform and
resuspended in 20 pi of TE buffer after ethanol precipitation. Concentration was
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determined by optical density at 260 nM. Analysis of 5 pg of the sample by
agarose gel electrophoresis showed the size to be 0.45 kb.

Run-off Transcription
A run-off transcription on the 446 bp PCR product was carried out by using
T7 RNA polymerase. The reaction has a total volume of 20 pi and contains 4 pi
of 5X transcription buffer, 2.4 pi of 25 mM rNTPs, 2 pi of 0.6 pg/pl DNA template,
10.6 pi of water and 1 pi of 35U/pl T7 RNA polymerase purchased from
Promega. The transcription 5X buffer contains 400 mM HEPES-KOH, pH 7.5, 60
mM MgCI2, 10 mM spermidine and 200 mM DTT. The mixture was incubated at
37°C for 4-6 hours. A 335 nucleotide RNA was expected from the reaction. The
reaction mixture was first run through a push column to remove unincorporated
mononucleotides and then extracted with phenol and chloroform and
resuspended in 20 pi of DEPC-treated water after ethanol precipitation.
Concentration was determined by optical density at 260 nM. Analysis of 2 pg of
the sample by denaturing agarose gel electrophoresis showed the RNA band to
fall between the markers of 0.3 and 0.4 kb. The RNA sample was stored at
-70°C. The sequence of the RNA produced is shown in Appendix 2.

Also, a line

diagram and the procedure of generation of this template-primer is shown in
Figure 10. The linear relationship between log (kb) and distance migrated is Log
(kb) = -0.411 x distance+ 0.719 as shown in Figure 11. The RNA sample has a
distance migrated of 2.9 cm and its corresponding size calculated from the linear
equation is 0.33659 kb.

5' end labeling of primer
The primers for primer extension reaction were 5' end labeled by [y-32P]ATP. In a 10 pi reaction, 10 pmol of primer, 30 pCi of [y-32P]-ATP and 8 U of T4
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Figure 10 A schematic representation of the method used to generate
random base template-primer.
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Figure 11 Plot of size of RNA markers (kb on log scale) against the distance
migrated. The arrow indicates the location of the run-off transcription product.
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polynucleotide kinase were combined in a 1X buffer containing 50 mM Tris-CI,
pH 9.0, 1 mM MgCb, 0.1 mM ZnCI2 and 1 mM spermidine. The mixture was
incubated at 37°C for 60 minutes and stopped by adding 2 pi of 0.5 M EDTA
and 50 pi of TE buffer and heating at 65°C for 5 minutes. The reaction mixture
was then run through a push column to remove unincorporated mononucleotides.

Annealing
The RNA335-DNA20 template-primer was prepared by combining 7.5 pmol
of DNA20 primer and 2.5 pg RNA335 template in 100 pi of the hybridization
buffer containing 50 mM Tris, pH 8.0, 80 mM KCI and 1 mM EDTA. The mixture
was incubated at 90°C for 3 minutes and shifted to 60°C to cool down to 25°C in
60 minutes. The annealed RNA335-DNA20 mixture has a final concentration of
75 nM.

Primer extension
Reaction of DNA synthesis on RNA335-DNA20 template-primer by RT was
visualized by autoradiography on an 8 M urea, 10% polyacrylamide gel. The
primer was 5' end labeled with [y-32P]-ATP before annealing to the template.
Each primer extension reaction contains 10 nM RNA335-DNA20, 50 pM dNTPs
and 0.1 pg/pl RT in 1X RT assay buffer. 7.5 pi of the reaction mixture was
withdrawn and stopped by the addition of 3 pi of stop solution at 0, 5, 15, 30, 45,
60, 90,120, 180 and 240 minutes.

Assays to determine Kh for random RNA template primer
The Kg for RNA335-DNA20 and RNA335-DNA12 was obtained by using
poly(rA)(dT) as a challenger. 0.1 pg/pl RT enzyme and p2P]-labeled RNA335DNA20 or RNA335-DNA12 (0 - 45 nM) were incubated on ice for 10 minutes to
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form an RT/template-primer complex.

0.2 pg/pl of poly(rA)(dT) and 50 pM

dNTPs were used to initiate the DNA synthesis on RT/template-primer complex
at 37°C for 30 minutes. In control reactions, poly(rA)(dT) was examined on its
ability to trap free RT molecules by combining RT, template-primer, and
poly(rA)(dT) at the same time before dNTPs were added to initiate the reaction.
10 pi of each reaction mixture was analyzed on an 8 M urea 10% polyacrylamide
gel.

The amount of unbound template-primer was evaluated from the

radioactivity of the unextended primer. The bands corresponding to the DNA 20mer or DNA 12-mer were excised, mixed with 5 ml of scintillation fluid and
counted.

The amount of RT/template-primer complex was calculated by

subtracting the amount of RNA335-DNA20 or RNA335-DNA12 used in the
reaction by the amount of free template-primer. The Kd was calculated by using
Eadie plot method.
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III. Results

Reconstitution of d 66/p 51 and

p 64/p 51

HIV-1 RTs, p66, p64, and p51, were expressed and purified from yeast £.
cerevisiae that carries the corresponding gene (Figure 6). According to the
previous studies on these three clones, the p66 molecules can associate as
homodimers (35) and p66 and p51 were shown to associate as heterodimers
(35). Also, it was demonstrated that p66/p66 retained approximately 80% of the
RT activity of the heterodimers (35). The C-terminal deletion in the mutant, p64,
was shown to abolish RNase H activity (96). But, the mutant retained wildtype
DNA polym erase activity and an Ordered Bisubstrate m echanism

of

polymerization (97). As shown in Figure 6, p66 contains 560 residues: Pro1 to
Leu560; p64 contains 538 residues: Pro1 to Ala538; and p51 contains 440
residues: Pro1 to Phe440. In order to study the structure-function relationships of
HIV-1 RT, these three clones of RT were reconstituted to the different forms of
enzyme : p66/p66, p66/p51, p64/p64, and p64/p51. SDS-PAGE analysis of each
individual clone and the reconstituted heterodimer is shown in Figure 7. The
effect of heterodimer formation on RNA-dependent DNA polymerase activity was
examined by using poly(rA)(dT)12.ia as template-primer.

As shown in Figure 12

and Figure 13, the amount of dTMP incorporated into poly(rA)(dT)12-1 s increases
when the enzyme concentration in the reaction increases and the heterodimer is
able to incorporate more dTMP into primer-template relative to homodimer when
both are at the same concentration. These results indicate that reconstitution of
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Figure 12 Reconstitution of p66/p51 heterodimer increases RT activity. The
incorporation of dTMPs on a poly(rA)(dT) template-primer was compared
between p66/p66 (■-■) and p66/p51 ( • - • ) by activity assays. Standard error for
each point was less than 5%.
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Figure 13 Reconstitution of p64/p51 heterodimer increases RT activity. The
incorporation of dTMPs onto poly(rA)(dT) template-primer was compared
between p64/p64 (■ •■ ) and p64/p51 ( • - • ) .
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p66 or p64 with p51 is able to increase the DNA polymerase activity on
poly(rA)(dT)i2-i 8- Also, since the RT activity increases when the corresponding
subunits were mixed and incubated, subunit interaction in both heterodimer
forms, p66/p51 and p64/p51, is stronger than that in either homodimer.

Processivity assays of RTs on poly(rA)(dT)
Processivity refers to the number of nucleotides a polymerase can add to
the nascent chain during polymerization before the polymerase dissociates from
the primer-template. Poly (U,G) was employed in the processivity assay as a
template-primer challenger; an excess of poly (U,G) was added to the assay
when the reactions were initiated. Since a preincubation with primer-template
preceded reaction initiation, HIV RT has already formed initiation complexes with
poly (rA)(dT) and incorporation of [3H]-dTMP will proceed while these complexes
are intact. However, when the enzyme dissociates from the new chain on the
original primer-template, the excess poly (U,G) "traps" the RT as it binds to a
template without a primer or complementary nucleotides. Thus, reinitiation is
prevented. The results of these processivity assays are shown in Figures 14-17.
As seen in Figure 14, the level of dTMP incorporation by the p66/p66 homodimer
continues to increase until approximately eight minutes, at which point the level
of incorporation becomes constant in the reaction with challenger. However, the
level of incorporation continues to increase normally in the unchallenged control
reactions. These results indicate that the homodimer catalyzes nascent chain
elongation on the same primer-template until it dissociates after eight minutes;
then the free homodimer is trapped by poly (U,G) and unable to incorporate any
more dTMP.

Similarly, in assays investigating the processivity of the

p66/p51 heterodimer, p64/p64 homodimer, and p64/p51 heterodimer (Figures 15
- 17), incorporation increases up to fifteen minutes, four minutes, and eight
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Figure 14 Assays to determine the processivity of p66/p66 homodimer.
indicates the incorporation of dTMP for unchallenged enzyme assay, and
indicates the incorporation of dTMP for enzyme assayed in the presence of
poly(U,G). The standard deviation of each point is less than 5%.
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Figure 15 Assays to determine the processivity of p66/p51 heterodimer.
indicates the incorporation of dTMP for unchallenged enzyme assay, and
indicates the incorporation of dTMP for enzyme assayed in the presence of
poly(U.G). The standard deviation of each point is less than 5%.
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Figure 16 Assays to determine the processivity of p64/p64 homodimer.
0 - 0 indicates the incorporation of dTMP for unchallenged enzyme assay, and
indicates the incorporation of dTMP for enzyme assayed in the presence of
poly(U.G). The standard deviation of each point is less than 5%.
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Figure 17 Assays to determine the processivity of p64/p51 heterodimer.
indicates the incorporation of dTMP for unchallenged enzyme assay, and
indicates the incorporation of dTMP for enzyme assayed in the presence of
poly(U,G). The standard deviation of each point is less than 5%.
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minutes respectively. These observations indicate that the order of processivity
of different forms of RT is : p66/p51 (15 min) > p66/p66, p64/p51 (8 min) >
p64/p64 ( < 4 min). The heterodimer of each wild type and C-terminal deletion
mutant was shown to be more processive than the corresponding homodimer.

Nitrocellulose Binding Assays to determine the

for PolvfrAMcm

The differences in processivity observed among different forms of HIV-1 RT
might be related to potentially different affinities of each enzyme form for the
primer-template. So, the affinity of different forms of enzyme to poly(rA)(dT) was
compared by binding assays.

The K<j was calculated based on the Eadie

method (100). The binding of RT enzyme (E) to primer-template (L) is decribed
by the following equation:
E + L <--> EL
Kd = [E][L]/[EL]
where [E] and [L] are the concentrations of the unbound enzyme and primertemplate, and [EL] is the concentration of enzyme-ligand complex.
In terms of the total enzyme concentration [Efo,
[E] = [E]0 - [EL]
the equations
[E0] - [EL] = Kd [EL]/[L] and
[EL] = [E0] -Kd [EL]/[L]
can be obtained. By plotting [Eo] - [EL] versus [EL]/[L] or [EL] versus [EL]/[L], Kd
can be evaluated form the slope of the curve.

As shown in Figure 18, the Kd of

wild type enzyme for poly(rA)(dT) was obtained by plotting [Eo] - [EL] versus
[EL]/[L], Similarly, as shown in Figure 19, [EL] versus [EL]/[L] was plotted to
obtain the Kd for the mutant enzyme. The resulting Kd for p66/p66, p66/p51,
p64/p64, and p64/p51 are 16.9±0.1, 12.8±0.3, 392+4, and 21.6±0.3 nM
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Figure 18 Eadie plot of nitrocellulose filter binding assays to determine the
affinity of p66/pp66 (▲•▲), p66/p51 ( • - • ) , and p51 ( l- K ) for poly(rA)(dT).
The standard deviation of each point is less than 5%.
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Figure 19 Eadie plot of nitrocellulose filter binding assays to determine the
affinity of p64/pp64 ( • - • ) , and p64/p51 (♦-♦)fo r poly(rA)(dT). The standard
deviation of each point is less than 5%.
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respectively. The relationship between processivity and affinity for poly(rA)(dT)
primer-template is shown in Table 2. Each heterodimer, p66/p66 or p64/p64, has
a higher affinity for the primer-template than its homodimer. These results
suggest that the increase in processivity seen in the heterodimer is due to the
p51 subunit.

Activity assays on RNA335-DNA20 bv the reconstituted enzvme

in. vivo. HIV-1 RT transcribes the viral RNA genome, which is a random
base template (23). Relative to poly(rA), a random base RNA template forms
complex secondary structures more easily. The wildtype HIV-1 RT has been
shown to have different processivities on random base RNA templates from
those on poly(rA) (67,81). Pausing can occur preferentially at certain nucleotide
positions during DNA synthesis on a random base RNA template (77). In order
to examine the relationship between RT structure and the DNA polymerase
function on the random base templates, a 335 nucleotide RNA was generated
from plasmid Bluescript by T7 RNA polymerase and used as the template for
transcription by RT (Figures 10,11). A 20 nucleotide oligomer was annealed to
this RNA template at a position such that 78 nucleotides could be added to the
primer for full length transcription (Figure 10). The incorporation of dNMP was
then compared between heterodimer and homodimer to investigate the
contribution of the p51 subunit to the enzyme activity on this random base RNA
template-primer.

As shown in Figures 20 and 21, the results obtained were

similar to those in which poly(rA)(dT) was the primer-template. The amount of
dNMP incorporated into RNA335-DNA20 increases when the enzyme
concentration in the reaction increases and the heterodimer is able to incorporate
more dNMP into this primer-template relative to homodimer when both are at the
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Table 2 Processivity and Kd of HIV-1 RT for poly(rA)(dT).
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Enzyme
Processivity
K d (n M )

p 6 6 /p 6 6 p 6 6 /p 5 1
8'

15'

16.9±0.1 1 2 .8 6 ± 0 .3

p 6 4 /p 6 4
<4 *
392±4

p 6 4 /p 5 1
g'
2 1 .6 ± 0 .5
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Figure 20 Reconstitution of p66/p51 increases RT activity on RNA335DNA20. The incorporation of dTMPs onto RNA335-DNA20 was compared
between p66/p51 ( • - • ) and p66/p66 (■-■).
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Figure 21 Reconstitution of p64/p51 increases RT activity on RNA335DNA20. The incorporation of dTMPs onto RNA335-DNA20 was compared
between p64/p51 ( • - • ) and p64/p64 (■-■).
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same concentration. These results indicate that reconstitution of p66 or p64 with
p51 is able to increase the DNA polymerase activity on RNA335*DNA20.

Primer extension on RNA335-DNA20 bv HIV-1 RT
It was observed that heterodimer is more processive than homodimer by
using poly(rA)(dT) as the template-primer as described above. It is important to
further investigate the processivity on the random base RNA template which is
the natural substrate of HIV-1 RT. A random base RNA template can form
secondary structure due to hydrogen bonds between bases.

Also, the RNA

sequence might carry information that will direct the polymerization by HIV-1 RT.
The influence of enzyme structure on processivity on a random base RNA
template could also be important. In these studies, since the primer was first 5'
end labeled with [32P]-ATP before it was annealed to the template, the extension
of the primer by RT can be visualized by autoradiography. The labeled RNA335DNA20 was incubated with RT enzyme for different periods of time so that the
effect of reaction time on extension pattern can be observed. DNA size markers
were used to indicate the size of the extended primer. Also, by referring to the
RNA template sequence, the sequences of pause sites were obtained.

The

primer extension patterns by homodimer and heterodimer of both wild type and
mutant enzyme were compared. The elongation of nucleotides was visualized by
an 8 M urea 10% polyacrylamide gel followed by exposure to the X ray film. The
results (Figures 22-25) showed that the DNA products extended by p64/p64
homodimer were mainly 38 nucleotides long with a small fraction of the products
at 23 to 25 nucleotides long. Unlike p64/p64, however, p66/p66 extended the
primer to mostly 38 nucleotides long. Mutant heterodimer, p64/p51, was able to
further extend the primer to 62 nucleotides long with small pausing at 43 to 44
nucleotides long. In comparison, the wildtype heterodimer was able to extend
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Figure 22 Primer extension by p64/p64 on RNA335-DNA20. Time course of
RNA-dependent DNA synthesis on the random base template by RT is shown on
an 8 M urea 10% polyacrylamide gel. Reactions were stopped at 0, 5,15, 30,45,
60, 90, 120, 180, and 240 minutes as described under Materials and Methods
(lanes 2 - 11). The primer (20-mer) alone (lane 1) was used to indicate the
position of the unextended primer. Lanes 12 - 1 4 are DNA size markers which
indicate the position of 25, 31, 33, 34, 35, 44, and 61-mer and were used to
determine the position of pause sites.
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Figure 23 Primer extension by p64/p51 on RNA335-DNA20. Time course of
RNA-dependent DNA synthesis on the random base template by RT is shown on
an 8 M urea 10% polyacrylamide gel. Reactions were stopped at 0, 5,15, 30, 45,
60, 90, 120, 180, and 240 minutes as described under Materials and Methods
(lanes 2 - 11). The primer (20-mer) alone (lane 1) was used to indicate the
position of the unextended primer. Lanes 12 -1 4 are DNA size markers which
indicate the position of 25, 31, 33, 34, 35, 44, and 61-mer and were used to
determine the position of pause sites.
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Figure 24 Primer extension by p66/p66 on RNA335-DNA20. Time course of
RNA-dependent DNA synthesis on the random base template by RT is shown on
an 8 M urea 10% polyacrylamide gel. Reactions were stopped at 0, 5,15, 30, 45,
60, 90, 120, 180, and 240 minutes as described under Materials and Methods
(lanes 2 - 11). The primer (20-mer) alone (lane 1) was used to indicate the
position of the unextended primer. Lanes 12 - 14 are DNA size markers which
indicate the position of 25, 31, 33, 34, 35, 44, and 61-mer and were used to
determine the position of pause sites.
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Figure 25 Primer extension by p66/p51 on RNA335-DNA20. Time course of
RNA-dependent DNA synthesis on the random base template by RT is shown on
an 8 M urea 10% polyacrylamide gel. Reactions were stopped at 0, 5,15, 30, 45,
60, 90, 120, 180, and 240 minutes as described under Materials and Methods
(lanes 2 - 1 1 ) .

The primer (20-mer) alone (lane 1) was used to indicate the

position of the unextended primer. Lanes 12 - 14 are DNA size markers which
indicate the position of 25, 31, 33, 34, 35, 44, and 61-mer and were used to
determine the position of pause sites.
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the primer to 62, 65, and 74 nucleotides long and more. Little earlier pauses
were detected for p66/p51 like those seen in p64/p51. These results indicate that
heterodimer is more processive than homodimer on RNA335-DNA20 templateprimer in both wildtype and mutant enzymes.

Furthermore, the C-terminal

deletion decreases the processivity of the enzyme.

Interaction of HIV-1 RTwith RNA335-DNA20
Since a correlation between processivity and the affinity of the enzyme for
poly(rA)(dT) was observed, it is important to determine if the processivity is also
correlated with the interaction between different RT forms and RNA335-DNA20.
The amount of RNA335-DNA20 bound by RT is proportional to the amount of the
primer that is extended when RT molecules can be trapped and prevented from
binding to the substrate provided that the RT-substrate complex dissociates after
a processive cycle of DNA synthesis. A diagram is shown in Figure 26 to depict
the method for investigating the interaction between RT and RNA335-DNA20.
RT was preincubated with [32 P]-labeled RNA335-DNA20 for 10 minutes on ice.
Poly(rA)(dT) and dNTPs were added to the mixture to initiate the reaction. The
presence of poly(rA)(dT) trapped the free RT molecules and hence prevented the
RT molecules from reassociating with RNA335-DNA20.

The ability of

poly(rA)(dT) to trap free RT molecules was demonstrated by incubating the RT
enzyme, RNA335-DNA20, and poly(rA)(dT) first before dNTPs were added to
initiate the reaction. The DNA synthesis on RNA335-DNA20 in the presence of
poly(rA)(dT) was poorly seen on the autoradiogram as compared to the primer
extension results without the presence of poly(rA)(dT).

These observation

suggest that poly(rA)(dT) is capable of competing the binding of RNA335-DNA20
to the RT molecules. In the binding assays, the bands corresponding to the
primer were excised and counted for the amount of unbound RNA335-DNA20.
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Figure 26 Scheme to determine Kd for RNA335-DNA20.
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The amount of the bound RNA335-DNA20 was obtained by subtracting the total
amount of RNA335-DNA20 used by the amount of the unbound RNA335-DNA20.
The Eadie plot method was used as described before to obtain the K<j for
RNA335-DNA20. The results showed that the K(js for RNA335-DNA20 were
8.6+0.5, 7.1±0.5, 6.0±0.5, and 18.0±0.5 nM for p64/p64, p64/p51, p66/p66, and
p66/p51 respectively as shown in Figure 27 -28. RNA335-DNA20 appeared to
bind to p64/p64/, p66/p66, and p64/p51 even tighter than to p66/p51 according to
the results, and the processivity on RNA335-DNA20 did not seem to have a
significant correlation with the KdS obtained in these binding assays.

Effect of primer length on affinity for substrate
The affinity for RNA335-DNA12 was examined between wildtype and
mutant heterodimers.

The RNA-DNA duplex must fit into a primer-template

binding groove in RT and contact both DNA polymerase and RNase H active
sites. A short primer might cause insufficient interaction with the binding groove
and hinder enzyme function.

By using the same method described for

determining the Kd for RNA335-DNA20, the Kd for RNA335-DNA12 is 27.7 and
2.1 nM for p66/p51 and p64/p51 respectively as shown in Figure 29.

The

random base RNA template hybridized with a 12-mer was shown to have a
weaker interaction with p66/p51 than that hybridized with a 20-mer. The mutant
heterodimer has a Kdfor RNA335-DNA12 smaller than that for RNA335-DNA20.
The random base RNA template-primer appeared to bind tightly to the nonwildtype enzyme as already observed.
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Figure 27 Eadie plot of binding assays to determine the affinity of p66/p66
(■ -■ ) and p66/p51 ( • - • ) for RNA335-DNA20. The standard deviation of each
point is less than 5%.
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Figure 28 Eadie plot of binding assays to determine the affinity of p64/p664
(■ -■ ) and p64/p51 ( # - # ) for RNA335-DNA20. The standard deviation of each
point is less than 5%.
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Figure 29 Eadie plot of binding assays to determine the affinity of p66/p51
(■ -■ ) and p64/p51 ( • - • ) for RNA335-DNA12. The standard deviation of each
point is less than 5%.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

69

0.35

0.05

0.4

EL/L

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

70

Relationship between the template sequence and pause sites of primer
extension
It has been observed that DNA template-directed polymerization by HIV-1
RT is error-prone for single nucleotide substitution, addition and deletion errors in
homopolymeric sequences (108). Also, it has been noted that strong termination
of processive synthesis occurs at these hot spots (108).

It is important to

investigate the RNA template sequences, presumably the potential mutation hot
spots, where the pauses of processive DNA synthesis tend to occur. As shown
in Figures 22-25, DNA synthesis by RT was paused when the primer was
extended to specific length. The sequences of the template where the primer
extension paused were compared as shown in Figure 30. The template
sequences that were related to the pause sites were found to be those rich in G
and C bases.

The progress of the DNA synthesis by HIV-1 RT was hence

dependent on the template sequence. This observation was further confirmed by
using two other primers which have the same 5' termini of the 20 nucleotide
primer used in the primer extension reaction as showed below :
20-MER

5'GGTCG ACGGT ATCGA TAAGC

12-MER

5'GGTCG ACGGT AT

25-MER

5'GGTCG ACGGT ATCGA TAAGC TTGAT

These three primers were extended to a same pause site (38 nucleotide
long) regardless of the length of the primers. Also, the ability to extend over the
G C rich template was found various in different form of HIV-1 RT. The wild type
heterodimer, p66/p51 was the enzyme most able to extend the primer over the G
C rich regions. These results suggest that the processivity of HIV-1 RT on
random base template depends on the template sequence. Certain template
sequences are able to command RT to pause the DNA synthesis.

Also, RT
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Figure 30 The sequence alignment of pause sites on random base template
byRT.
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structure plays an important role in rebinding the primer-template and further
extending the terminated primers.
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IV. Conclusions and Discussion

In this study, the significance of the p51 subunit and the C-terminal RNase
H domain of p66 in RNA-dependent DNA synthesis by HIV-1 RT was
investigated. A C-terminal deletion mutant, p64, was used in this investigation.
This mutant was shown to have an Ordered Bisubstrate mechanism in its DNA
synthesis as in the wildtype enzyme and lacks RNase H activity as described
before (97). The deletion includes residues His539 to Leu560 which constitute a
loop that connects (3 sheet 5 to a helix E and the entire a helix itself as shown in
Figure 31.

Mutations at His539 have been shown to reduce both substrate

binding and catalytic rate (105). Also, residues 534 to 545 in HIV-1 RT are the
most highly conserved stretch of 12 amino acids in five lentivirus RNase H
sequences as shown in Figure 32 (105). According to the crystal structure, p66
appears to be the catalytic subunit by providing a cleft for substrate binding and
catalysis sites for DNA polymerase and RNase H activity.

However, p51

assumes a different structure and is the non-catalytic subunit (50). The RNase H
domain of p66 is responsible for hydrolyzing the RNA template on RNA-DNA
duplex during DNA synthesis. Physical contact between the RNase H domain
and the primer-template was suggested by computer modeling of HIV-1 RT and
RNA-DNA interaction (50). It is hence important to understand the effects of the
deletion of these conserved residues on the processivity and primer-template
binding.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 31 C-terminal deletions in the RNase H domain of HIV-1 RT. The
amino acid sequence and the secondary structure assignments for the RNase H
domain are shown according to the crystal structure (98). The amino acid deleted
in the mutant enzyme ( p64 or RT4) is underlined.
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Figure 32 The deletion in the mutant RT contains part of the conserved
residues present in RNase H domains of lentiviruses. (HIV-2, human
immunodeficiency virus type 2; SIV, simian immunodeficiency virus from
macaque monkey; EIVA, equine infectious anemia virus; VISNA, visna lentivirus)
These conserved residues are thought to cluster near the catalytic site (98).
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guided by the direct repeat sequence (R) on both ends of the RNA, and minus
strand DNA synthesis proceeds to the 5' end of the RNA (PBS). The primer for
plus strand DNA synthesis is derived from the RNA genome at a highly
conserved region called the polypurine tract (PPT), which is located near the U3
region at the 5' end of the minus strand DNA. The synthesis of the plus strand
DNA is initiated from PPT and continued to the PBS of tRNA. This DNA plus
strand is then translocated to the 3' end of the minus strand, guided by the PBS
sequences at 3' end of both plus and minus strands. The tRNA and the primer
for plus strand synthesis are subsequently removed by a precise RNase H
cleavage that defines the right and left ends of the LTRs, respectively (55-57,5962). The sequences of the LTRs are important for the integration of the viral
DNA into the host cell chromosome. The LTRs also contain promoter, enhancer,
and termination signals for gene expression. The synthesis of viral DNA is
complete after both strands are extended to the 5' end of the complementary
strand. The RNase H activity associated with HIV-1 RT is involved in selective
degradation of RNA in the DNA hybrid and in generation of an RNA primer for
synthesis of plus strand DNA (25, 43, 63-65). It is also responsible for specific
removal of the host tRNA primer as well as the plus strand primer by specific
cleavage at RNA-DNA junction.
The residues Pro1 through Tyr266 of HIV-1 RT are thought to be required
for polymerase domain (47).
polymerase active site (50).

Asp 185 and Asp186 are required in the
A bireactant - biproduct mechanism has been

proposed for DNA synthesis by HIV-1 RT (66, 67). In this mechanism, binding of
the reactants is ordered with the primer-template binding first followed by the
binding of the 2'-deoxynucleoside 5'-triphosphate (dNTP) that is complementary
to the next appropriate template residue as shown in Figure 5. The incorporation
of the dNMP into the nascent chain then occurs via an Sn 2 displacement of
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The dissociation constant (K<j) for poly(rA)(dT) obtained by nitrocellulose
binding assays suggested that the processivity of HIV-1 RT on poly(rA)(dT)
correlates with the affinity for the substrate as summarized in Table 2. These
results support the hypothesis that p51 acts to enhance the processivity of DNA
synthesis by improving the affinity for primer-template.

It is conceivable that

having an RNase H domain on both subunits as in the p66/p66 and p64/p64
homodimers can cause interference in primer-template binding.
It has been proposed that the processivity of a polymerase comes from a
tight interaction between enzymes and certain repeating motifs in the substrate;
distributive enzymes bind to the motifs that do not repeat (103). Also, it has been
reported that processivity numbers of HIV-1 RT can vary widely with the template
used, increasing from a few to > 300 nucleotides (104). It is hence important to
examine the enzyme function on templates other than poly(rA), particularly those
with random bases instead of repeating the same base.

A 335 nucleotide

random base RNA template was then synthesized for the further studies. This
template was hybridized with a 20 nucleotide primer (Figures 10 and 11).
Processivity on this RNA335-DNA20 was seen to be affected by both the enzyme
structure and pause sites as observed on the autoradiograms (Figures 22-25). In
Figure 22, strong pause sites at 23, 24, and 38 nucleotides by p64/p64 mutant
homodimer were observed. This C-terminal deletion mutant homodimer, which
has a defect in RNase H function, a physical deletion in the polypeptide , and
extra 98 residues in the non-catalytic subunit, was distributive for the first 3-5
nucleotides incorporation. In p64/p51 (Figure 23), primers were extended to 38
nucleotides before any major pause sites were observed. The major pause site
at 38 nucleotides

was also observed in p66/p66 as in p64/p51.

However,

p64/p51 was seen to be able to further extend the primer to 62 nucleotides. This
observation indicates that p64/p51 is more active than p66/p66 in terms of DNA

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

78

synthesis on RNA335-DNA20. The extra RNase H domain was seen to cause
hindrance when comparing the primer-extension pattern by p64/p51 heterodimer
to those by p66/p66 and p64/p64 homodimer. Also, p51 was seen to contribute
to processivity when the primer extension patterns by p66/p66 and p66/p51 are
compared.

Although, the pause site at 38 nucleotides was also observed in

p66/p51, the longer DNA products (74 nucleotides and more) predominated. The
order of processivity on RNA335-DNA20 was: p66/p51> p64/p51> p66/p66>
p64/p64.

The enzyme structure was shown to play an important role in

processivity on RNA335-DNA20 as on poly(rA)(dT). This dependence of
processivity on enzyme structure was further studied by examining the interaction
between RNA335-DNA20 and the different forms of enzyme.
As described above, the increases in enzyme activity and processivity on
poly(rA)(dT) are correlated with the interaction between RT enzyme and
po!y(rA)(dT). Alteration in enzyme structure cause changes in enzyme affinity for
poly(rA)(dT) and hence influence the enzyme activity and processivity. It is
conceivable that the less processive RT molecules associate with lower affinity
for RNA335-DNA20. However, when KdS were examined (Figures 27 and 28),
an opposite result was obtained. The p66/p51 heterodimer maintains a Kd for
RNA335-DNA20 similar to that for poly(rA)(dT). But, p66/p66, p64/p64, and
p64/p51 appeared to interact with RNA334-DNA20 stronger than p66/p51 and
had higher affinity for this random base template-prim er than that for
poly(rA)(dT). Since the binding assays to determine the Kd for RNA335-DNA20
depends on the ability of poly(rA)(dT) to trap the free RT, and poly(rA)(dT) was
already shown to have different affinity for different forms of RT, the KdS for
RNA335-DNA20 observed might be affected by the failure of poly(rA)(dT) to trap
all the free RT molecules. For example, the p64/p64 has a Kd of 392 nM for
poly(rA)(dT), and the use of poly(rA)(dT) to trap the free p64/p64 could have

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

79

failed to prevent all the p64/p64 molecules from reassociating with RNA335DNA20. This problem was prevented by using excess of poly(rA)(dT) to favor the
form ation of RT-poly(rA)(dT) complex.

In a control reaction where RT,

poly(rA)(dT), and RNA335-DNA20 were incubated at the same time before the
reaction was initiated, the amount of poly(rA)(dT) used was shown to be able to
trap RT. The [32P]-labeled primer in this control reaction was poorly extended as
judged by the autoraiogram.

The tight interaction between random RNA

template-primer and the non-wildtype enzyme was further observed when
RNA335-DNA12 was used to study the effect of primer length on enzyme affinity
for substrate (Figure 29). As summarized in Table 3, the non-wildtype RT
molecules have smaller K<jS for random base RNA template-primer than the
p66/p51 wildtype enzyme.

Table 3 Summary of the measured dissociation constants (nM) of
HIV-1 RT for random base RNA template-primer.

p66/p51

p64/p51

RNA335-DNA20

18.0±0.5

7.1 ±0 .5

RNA335-DNA12

27.7±0.5

template-primer

p 6 4 /p 6 4

p 6 6 /p 6 6

8.6± 0.5

6 .0±0.5

2.1 ±0.5

The p64/p51 molecules appeared to have stronger interaction with RNA335DNA12 than RNA335-DNA20. However, the wildtype enzyme, p66/p51,
demonstrated a weaker affinity for RNA335-DNA12 than for RNA335-DNA20.
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This result was similar to that observed by Beard (74). In his studies, short oligo
(dT) primers (less than 14 nucleotides), annealed to poly(rA), bound RT relatively
weakly (Kd = 2 0 - 3 0 nM), whereas oligo (dT) primers of 16 and 20 nucleotides in
length bound tightly to RT (Kd - 0.1 nM). The results of the binding assays
suggest the processivity on RNA335-DNA20 does not depend on the dissociation
constant of RT for this template-primer. The tight interaction observed could be
because the substrate binding in those non-wildtype enzymes is more sensitive
to the nature of the primer-template. Strong premature termination was seen in
the primer extension on RNA335-DNA20 by the non-wildtype enzyme.

This

observation suggests that these RT molecules, after binding and short extending
the primer, either dissociate from and lose affinity for the primer-template or
remain bound to the primer-template without any further extension.

A “stall"

mechanism has been proposed to explain the premature termination in DNA
synthesis by HIV-1 RT (78).

This mechanism suggested that the enzyme

remains bound strongly to the primer-template and allows no further DNA
synthesis.
The pauses of DNA synthesis tended to occur at template positions
containing poly G,C sequences as shown in Figure 30. This dependency of
pause sites on template sequence was confirmed by using a 12-mer and a 25mer as primer which have the same 5‘ termini of the 20-mer. The major pause
site, 38-mer, was seen to be independent of the position of the 3' end of the
primer but dependent on the template sequence.

The template sequence

flanking the pause sites are shown in Figure 33. The G-C sequence dependence
of the pause sites is an important area to study to elucidate why HIV-1 RT can
catalyze synthesis over all the G-C rich stretches in its RNA genome to complete
the transcription. Mutations might be required for RT to transcribe over these GC rich pause sites.

Furthermore, an auxiliary viral or cellular factor might be
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Figure 33 The tem plate sequences around the pause sites for DNA
synthesis by HIV-1 RT on RNA335-DNA20. The length of the paused product
and seven bases upstream and down stream the pause site are shown. The poly
G or C stretches are underlined.
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involved in the process. The G-C rich stretches are likely forming secondary
structure through intra- or intermolecular interaction between G and C bases and
hence blocking the DNA synthesis. It is also possible that HIV-1 RT contains
substrate binding subsites for the RNA template, similar to those known for
RNase A and that these subsites happen to have strong affinity for G and C
bases.

If this hypothetical subsite scenario is correct, then polymerization

proceeds across the RNA template in a processive fashion through AT rich
areas. However, when HIV-1 RT encounters several G and C bases in a row,
most of the subsites interact with G or C and hence lock the primer-template.
The DNA synthesis is then terminated by the "stall" mechanism described above.
On the other hand, it is also possible that the subsites have very loose affinity for
G and C and the termination of DNA synthesis is a consequence of the loose
interaction between enzyme and G-C rich areas of the primer-template. HIV-1
RT falls off the primer-template and fails to extend the primer over the G-C rich
template.
The processivity data of p64/p51 and p66/p51 showed that the C-terminal
deletion can reduce the processivity of DNA synthesis on both poly(rA)(dT) and
RNA335-DNA20.

Since the mutant enzyme still m aintains its Ordered

Bisubstrate mechanism in DNA synthesis, this 22 amino acid deletion in the
RNase H domain does not affect the assembly of the functional polymerase
domain, but it is important in processivity. Similar results were observed in a
Gln475Glu mutant of HIV-1 RT which has retarded RNase H function (107). In
the primer extension study, the primers were not extended by p64/p51 as well as
they were by p66/p51.

A catalytically functional RNase H domain is hence

required to facilitate processive DNA synthesis and reinitiation of the DNA
synthesis at specific pause sites. The role of the RNase H activity in facilitating
DNA synthesis was also observed by Dudding et al. (90). However, as seen in
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the processivity and primer extension data by p66/p66, although a functional
RNase H domain was present in the homodimer, the processivity was still
reduced and the primer was not well extended. It is likely the extra RNase H
domain in the non-catalytic subunit causes hindrance to DNA synthesis. It is also
possible that the folding of the non-catalytic p66 is less capable of maintaining
the favorable enzyme conformation than p51 in the wildtype.
It is hoped that the knowledge of structure-function relationships of HIV-1
RT will facilitate the design of new inhibitors of this enzyme and suggest
strategies that might help to circumvent the ability of mutant RT molecules to
escape the potency of inhibitors. In this investigation, the p51 subunit is seen to
contribute significantly to enzyme activity and processivity of HIV-1 RT. The
extra RNase H domain in the small subunit can decrease the enzyme function,
as seen in p66/p66 and p64/p64. The p51 subunit, although harbors no catalytic
sites, plays an important role in maintaining the favorable conformation of the
enzyme. Hence, molecules that can disrupt the interaction between subunits are
potential HIV-1 RT inhibitors.

The C-terminal deletion in p64/p51 causes

decreases in enzyme activity and processivity.

Since the HIV-1 RT DNA

polymerase activity is correlated with its RNase H domain, inhibitors that can
affect the RNase H function or alter its conformation can be useful in blocking the
DNA synthesis. G-C rich sequences of RNA template is shown to be able to
command the RT to pause the DNA polymerization. Introduction of molecules
that can prevent the RT from reinitiating the DNA synthesis on these pause sites
is hence one of the antiviral strategies.
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APPENDIX 1

A. pBluescript (+) sequence for generating the 446 bp DNA fragment

530

540

*

550

•

560

•

570

•

•

GCTG GCGAA GGGGG GATGT GCTGC AAGGC GATTA AGTTG GGTAA CGCCA
PCR primer 1

580

590

•

600

*

610

*

620

*

*

GGGTT TTCCC AGTCA CGACG TTGTA AAACG ACGCC CAGTG AATTG TAATA
T7

630

640

*

•

650

660

*

670

*

*

CGACT CACTA TAGGG CGAAT TGGAG CTCCA CCGCG GTGGC GGCCG CTCTA
Promoter
+1

680
*

690

700

*

*

710
i

720
•

GAACT AGTGG ATCCC CCGGG CTGCA GGAAT TCGAT ATCAA GCTTA TCGAT

730

740

750

760

770

*

*

*

*

•

ACCGT CGACC TCGAG GGGGG GCCCG GTACC CAGCT TTTGT TCCCT TTAGT

780

790

*

*

810
*

GAGGG TTAAT TCCGA GCTTG

830

800

•

820

*

*

GCGTA ATCAT GGTCA TAGCT GTTTC CTGTG

840

850

860

870

*

*

*

•

TGAAA TTGTT ATCCG CTCAC AATTC CACAC AACAT ACGAG CCGGA AGCAT

880
*

890
*

900

910

*

*

920
*

AAAGT GTAAA GCCTG GGGTG CCTAA TGAGT GAGGT AACTC ACATT AATTG

930
*

940
*

950
*

960
*

970
*

CGTTG CGCTC ACTGC CCGCT TTCCA GTCGG GAAAC CTGTC GTGCC AG
GCC CTTTG GACAG CACGG TC
PCR primer 2
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APPENDIX 2

B. Sequence of the random base RNA template

10

20

*

30

*

40

*

50

*

*

GGGCG AAUUG GAGCU CCACC GCGGU GGCGG CCGCU CUAGA ACUAG UGGAU

60

70

•

80
•*

CCCCC GGGCU

90

100

•

*

GCAGG AAUUC GAUAU CAAGC UUAUC GAUAC CGUCG ACCUC

CG AATAG CTATG GCAGC TGG 5'
20-MER
110

120

*

130

*

140

*

150

*

*

GAGGG GGGGC CCGGU ACCCA GCUUU UGUUC CCUUU AGUGA GGGUU AAUUC

160

170

•

180

•

190

*

200

•

*

CGAGC UUGGC GUAAU CAUGG UCAUA GCUGU UUCCU GUGUG AAAUU GUUAU

210
*

220
*

230
*

240
*

250
*

CCGCU CACAA UUCCA CACAA CAUAC GAGCC GGAAG CAUAA AGUGU AAAGC

260
•

270
*

280
*

290
*

300
*

CUGGG GUGCC UAAUG AGUGA GGUAA CUCAC AUUAA UUGCG UUGCG CUCAC

310
*

320
*

330
*

UGCCC GCUUU CCAGU CGGCA AACCU GUCGT GCCAG
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